Shield Therapeutics plc
Shield Therapeutics plc (SHIEF) Stock Overview
Explore Shield Therapeutics plc’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
150.9M
P/E Ratio
-9.64
EPS (TTM)
$-0.02
ROE
1.40%
SHIEF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Shield Therapeutics plc (SHIEF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.09, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.10.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.64 and a market capitalization of 150.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.